[HTML][HTML] What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2
The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
has caused more than 1 million deaths in the first 6 months of the pandemic and huge …
has caused more than 1 million deaths in the first 6 months of the pandemic and huge …
Antibody tests for identification of current and past infection with SARS‐CoV‐2
Background The diagnostic challenges associated with the COVID‐19 pandemic resulted in
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. Serology …
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. Serology …
Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis
Objective To determine the diagnostic accuracy of serological tests for coronavirus disease-
2019 (covid-19). Design Systematic review and meta-analysis. Data sources Medline …
2019 (covid-19). Design Systematic review and meta-analysis. Data sources Medline …
SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys
Background Population-based data on COVID-19 are essential for guiding policies. There
are few such studies, particularly from low or middle-income countries. Brazil is currently a …
are few such studies, particularly from low or middle-income countries. Brazil is currently a …
[HTML][HTML] Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases
A Vojdani, D Kharrazian - Clinical Immunology (Orlando, Fla.), 2020 - ncbi.nlm.nih.gov
Since the outbreak of COVID-19 caused by SARS-CoV-2, we tested 5 different blood
specimens that were confirmed positive for SARS-CoV-2 IgG and IgM antibodies [1]. The …
specimens that were confirmed positive for SARS-CoV-2 IgG and IgM antibodies [1]. The …
Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review
Coronaviruses are an extensive family of viruses that can cause disease in both animals
and humans. The current classification of coronaviruses recognizes 39 species in 27 …
and humans. The current classification of coronaviruses recognizes 39 species in 27 …
Humoral responses and serological assays in SARS-CoV-2 infections
Y Galipeau, M Greig, G Liu, M Driedger… - Frontiers in …, 2020 - frontiersin.org
In December 2019, the novel betacoronavirus Severe Acute Respiratory Disease
Coronavirus 2 (SARS-CoV-2) was first detected in Wuhan, China. SARS-CoV-2 has since …
Coronavirus 2 (SARS-CoV-2) was first detected in Wuhan, China. SARS-CoV-2 has since …
The spectrum of COVID-19–associated dermatologic manifestations: An international registry of 716 patients from 31 countries
Background Coronavirus disease 2019 (COVID-19) has associated cutaneous
manifestations. Objective To characterize the diversity of cutaneous manifestations of COVID …
manifestations. Objective To characterize the diversity of cutaneous manifestations of COVID …
[HTML][HTML] Evaluation of a novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples
Objectives In the context of the coronavirus disease 2019 (COVID-19) pandemic, the
development and validation of rapid and easy-to-perform diagnostic methods are of high …
development and validation of rapid and easy-to-perform diagnostic methods are of high …
The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection
P Kellam, W Barclay - Journal of General Virology, 2020 - microbiologyresearch.org
SARS-CoV-2 is a novel coronavirus that is the causative agent of coronavirus infectious
disease 2019 (COVID-19). As of 17 April 2020, it has infected 2 114 269 people, resulting in …
disease 2019 (COVID-19). As of 17 April 2020, it has infected 2 114 269 people, resulting in …